The Scientist

» NIH funding, genetics & genomics and culture

Most Recent

image: Image of the Day: Fungal Forms

Image of the Day: Fungal Forms

By | April 20, 2017

By sequencing and analyzing the genomes of more than 20 species of Penicillium fungi, researches uncovered genes encoding for numerous bioactive compounds, including antibiotics.

0 Comments

image: CRISPR Corrects Duchenne-Causing Mutations

CRISPR Corrects Duchenne-Causing Mutations

By | April 12, 2017

Using CRISPR-Cpf1 gene editing, researchers have fixed mutations that cause a form of muscular dystrophy in cultured human cardiomyocytes and a mouse model.

0 Comments

Scientists identify a mutation in the CRY1 gene in people with abnormal sleeping patterns.

0 Comments

23andMe customers can now receive information about genetic risk for diseases including Parkinson’s and celiac.

0 Comments

Octopus, cuttlefish, and squid extensively edit messenger RNAs in an evolutionarily conserved process. 

0 Comments

image: Cross-Sample Sequencing Contamination Galore

Cross-Sample Sequencing Contamination Galore

By | April 5, 2017

Scientists conducting a large-scale, comparative transcriptomics project have inadvertently highlighted widespread contamination in sequencing data.

3 Comments

image: Trump Meets with HHS, NIH Brass

Trump Meets with HHS, NIH Brass

By | April 5, 2017

President Donald Trump, HHS Secretary Tom Price, and NIH Director Francis Collins discussed the opioid crisis and retaining young researchers in the biomedical research enterprise, among other things, according to a White House official.

0 Comments

Both Democrats and Republications criticize the Trump administration’s plan to cut funding for biomedical research.

0 Comments

image: Mutations Linked to Secondary Cancers

Mutations Linked to Secondary Cancers

By | April 4, 2017

Childhood cancer survivors with mutations in certain cancer-risk genes have a higher risk of developing additional neoplasms later in life, according to research presented at the American Association for Cancer Research annual meeting.

0 Comments

At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.

0 Comments

Popular Now

  1. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. Consilience, Episode 3: Cancer, Obscured
  4. A History of Screening for Natural Products to Fight Cancer
AAAS